Direct Labelling of Beta 2-adrenoceptors. Comparison of Binding Potency of 3H-ICI 118,551 and Blocking Potency of ICI 118,551
Overview
Authors
Affiliations
A radioligand that selectively labels beta 2-adrenoceptors, 3H-ICI 118,551 (3H-ICI), is introduced. Experiments were performed on guinea-pig tissues. The binding characteristics of 3H-ICI on lung membrane particles are compared with the blocking characteristics of ICI 118,551 against the tracheo-relaxant effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol. Binding to both beta 1- and beta 2-adrenoceptors were also performed with 3H-(-)-bupranolol on lung and ventricular myocardium. The binding inhibition characteristics of unlabelled ICI 118,551 on ventricle were compared with its characteristics as antagonist of the positive chronotropic effects of (-)-noradrenaline, (-)-adrenaline and (+/-)-fenoterol in spontaneously beating right atria. 1. ICI 118,551 blocked more the relaxant effects of (+/-)-fenoterol and (-)-adrenaline than those of (-)-noradrenaline on trachea. The positive chronotropic effects of (+/-)-fenoterol on sinoatrial node were blocked more than those of both (-)-adrenaline and (-)-noradrenaline. A non-linear regression analysis of blocking data with ICI 118,551 according to the model of Lemoine and Kaumann (1983) revelas that both beta 1- and beta 2-adrenoceptors contribute to the tracheo-relaxant and positive chronotropic effects of agonists. The estimated equilibrium dissociation constants pKB (-log KB = pKB; mol/l) were 7.1 and 9.6 for beta 1- and beta 2-adrenoceptors, respectively. Tracheal beta 2-adrenoceptors contribute 99%, 97% and 7%, sinoatrial beta 2-adrenoceptors contribute 76%, 3% and 0% to the fractional stimuli induced by (+/-)-fenoterol, (-)-adrenaline and (-)-noradrenaline, respectively. 2. 3H-ICI associated to beta 2-adrenoceptors of lung membranes with a kon of 0.521 X nmol-1 X min-1 and dissociated with a koff of 0.19 min-1. 3H-ICI bound to lung beta 2-adrenoceptors with an equilibrium dissociation constant pKL* of 9.2. Unlabelled ICI 118,551, (-)-bupranolol, (+)-bupranolol, (-)-adrenaline, (-)-noradrenaline and (+/-)-fenoterol competed with 3H-ICI for lung beta 2-adrenoceptors with pKL-values of 9.0, 9.4, 8.1, 5.9, 4.9 and 6.4, respectively. 3. 3H-(-)-bupranolol associated to beta-adrenoceptors of lung membranes with a kon 1.21 X nmol-1 X min-1 and dissociated with a koff of 0.26 min-1. 3H-(-)-bupranolol bound to lung beta 2-adrenoceptors and to heart beta 1-adrenoceptors with a pKL of 9.6 and a pKL of 8.8, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
Mo W, Michel M, Lee X, Kaumann A, Molenaar P Br J Pharmacol. 2017; 174(16):2706-2715.
PMID: 28574581 PMC: 5522995. DOI: 10.1111/bph.13897.
Ruzsnavszky F, Hegyi B, Kistamas K, Vaczi K, Horvath B, Szentandrassy N Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(5):457-67.
PMID: 24566722 DOI: 10.1007/s00210-014-0964-6.
Tanaka Y, Yamashita Y, Michikawa H, Horinouchi T, Koike K Naunyn Schmiedebergs Arch Pharmacol. 2007; 375(1):51-64.
PMID: 17237919 DOI: 10.1007/s00210-006-0130-x.
Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
Niclauss N, Michel-Reher M, Alewijnse A, Michel M Naunyn Schmiedebergs Arch Pharmacol. 2006; 374(2):99-105.
PMID: 17028849 DOI: 10.1007/s00210-006-0104-z.
Ponicke K, Groner F, Heinroth-Hoffmann I, Brodde O Br J Pharmacol. 2006; 147(7):714-9.
PMID: 16474418 PMC: 1751514. DOI: 10.1038/sj.bjp.0706674.